Last reviewed · How we verify
NCT03525899
Macular Hole After Diabetic Vitrectomy
trial testing Pars plana vitrectomy in Proliferative Diabetic Retinopathy in 7 participants. Completed in 1 December 2017.
1 December 2017
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 7 |
| Start date | 1 November 2017 |
| Primary completion | 1 December 2017 |
| Estimated completion | 1 December 2017 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Pars plana vitrectomy
Conditions studied
- Proliferative Diabetic Retinopathy — all drugs for Proliferative Diabetic Retinopathy →
- Macular Holes — all drugs for Macular Holes →
Sponsor
National Taiwan University Hospital
Who can join
Adults 18 to 80, any sex, with Proliferative Diabetic Retinopathy or Macular Holes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To present the clinical characteristics and rational treatment of macular hole (MH) after the diabetic vitrectomy (DV) in patients with proliferative diabetic retinopathy (PDR).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03525899
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pars plana vitrectomy
Trials testing the same drug.
- NCT07495319 — Influence of Tamponade on Retinal Shift in Eyes Undergoing Vitrectomy for Rhegmatogenous Retinal Detachment: A Compariso · NA · completed
- NCT06927544 — Intraocular Gas Tamponade for Treatment of Large Idiopathic Macular Holes · NA · enrolling by invitation
- NCT06358664 — Caffeine and Cataract After Pars Plana Vitrectomy · NA · recruiting
- NCT05658237 — Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA) · NA · active not recruiting
- NCT05561569 — Air Versus Gas Tamponade in Primary Retinal Detachment · NA · unknown
Other recruiting trials for Proliferative Diabetic Retinopathy
Currently open trials in the same condition.
- NCT06549023 — Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy · NA · recruiting
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03525899 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 16 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525899.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing